In a patient with rheumatoid arthritis who reduced prednisolone to 10 mg five days ago, has a dental infection and recent liver, kidney, and lung problems, and received two intra‑articular steroid injections in both knees, should I increase his prednisolone back to 20 mg daily and postpone further joint injections?

Management of Prednisolone Dosing in RA Patient with Recent Steroid Injections and Active Infection

Do not increase the prednisolone back to 20 mg daily in this patient with an active dental infection, recent organ complications, and recent intra-articular steroid injections—instead, maintain the current 10 mg dose while aggressively treating the infection, and avoid any further joint injections until the infection is completely resolved.

Rationale for Maintaining Current Dose

The combination of active infection with recent high-dose systemic and intra-articular corticosteroids creates a dangerous scenario for infection complications. Here's the algorithmic approach:

Infection Risk Assessment

Active dental infection + immunosuppression = high-risk situation. The evidence clearly demonstrates that glucocorticoid therapy, particularly at doses >10 mg/day, significantly increases infection risk in RA patients 1. One study showed dose-dependent infection risk with doses 6-10 mg/day (RR=1.95) and even <5 mg/day (RR=1.32) 2. More critically, doses >10-15 mg/day showed dramatically increased adverse events (OR=32.3) 3.

The patient just received bilateral knee injections 5 days ago, which compounds the infection risk. Intra-articular corticosteroids suppress local immune responses, and when combined with systemic steroids and active infection elsewhere (dental), this creates a perfect storm for septic complications 4. Septic arthritis risk is specifically elevated with repeated joint punctures and TNF-inhibitor use in the first 6 months 4.

Why Not Increase to 20 mg

Increasing to 20 mg would:

• Double the infection risk in a patient already infected
• Potentially mask signs of worsening infection (fever, inflammatory markers)
• Increase risk of septic arthritis in recently injected joints
• Substantially elevate risk of serious adverse events including opportunistic infections (60.6 per 1000 person-years) 5

Stress Dose Considerations

The EULAR guidelines address your concern about adrenal insufficiency 1. For a patient on 10 mg prednisolone with a dental infection (not major surgery or septic shock), stress dosing is NOT indicated. The guideline recommends stress dosing primarily for acute severe illness requiring hospitalization. A dental infection being treated does not meet this threshold.

However, the patient must not abruptly stop or further reduce the 10 mg dose during the infection, as HPA axis suppression is expected after chronic use >7.5 mg for >3 weeks 1.

Management Algorithm

Immediate Actions (Days 1-7):

1. Maintain prednisolone at 10 mg daily (do not increase, do not decrease)
2. Aggressively treat dental infection with appropriate antibiotics
3. Monitor closely for signs of:
   • Septic arthritis in injected knees (increased warmth, effusion, pain out of proportion)
   • Systemic infection worsening
   • New joint involvement

Short-term (Weeks 2-4):

1. Once infection completely resolved (not just improved), consider gradual taper by 1 mg decrements every 2-4 weeks 6
2. Absolutely postpone any further joint injections until infection cleared AND at least 6 weeks from last injection 7

Monitoring Parameters:

• Temperature daily
• Joint examination of knees every 2-3 days initially
• CRP/ESR if clinical concern for worsening
• Ensure patient knows to report immediately: fever >38°C, increased knee swelling/warmth, systemic symptoms

Critical Pitfalls to Avoid

Do not reflexively increase steroids for RA flare during active infection. The mortality risk from uncontrolled infection far exceeds the morbidity from temporary suboptimal RA control. The recent knee injections should provide local anti-inflammatory effect for weeks to months 7.

Do not inject joints again until:

• Infection completely resolved (minimum 2-4 weeks after treatment completion)
• At least 6 weeks from previous injection 7
• Rule out any possibility of bacteremia or septic arthritis

Do not forget the liver, kidney, and lung problems mentioned. These comorbidities further increase infection risk and complicate steroid metabolism 1. The 10 mg dose is already at the upper limit of "low-dose" therapy where adverse events accelerate 3.

The patient's RA may flare slightly during this period, but infection control takes absolute priority over inflammation control in this clinical scenario. The bilateral knee injections from Friday should continue providing local benefit even as systemic dose remains at 10 mg.